A phase 2 study of pamiparib in the treatment of patients with locally advanced or metastatic HER2-negative breast cancer with germline BRCA mutation.Tao Sun,Yanxia Shi,Jiuwei Cui,Yongmei Yin,Quchang Ouyang,Qiang Liu,Qingyuan Zhang,Yiding Chen,Shao Zhimin, Shouman Wang,Xiaojia Wang,Zhongsheng Tong,Yahua Zhong,Min Yan,Xi Yan,Chuan Wang,Haiyuan Yang,Miao Li,Xiao Xiang,Binghe XuJOURNAL OF CLINICAL ONCOLOGY（2021）引用 9|浏览6暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
